The Latest Breaking News from Elevance Health

The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.46%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.71%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.31%. US stock indexes this morning are moderately higher. Stocks are finding support on...

June S&P 500 E-Mini futures (ESM24) are up +0.12%, and June Nasdaq 100 E-Mini futures (NQM24) are up +0.27% this morning as investors awaited a new round of U.S. economic data, comments from Federal Reserve officials, as well as corporate earnings reports, with the spotlight on results from streaming giant…

Although the Fed might opt for a softer stance on the rate hike at the policy meeting this week, the fears of further aggressive rate hikes later this year remain. This, along with the banking crisis, is fueling recession concerns. Therefore, investing in defensive stocks McDonald’s (MCD), Elevance Health (ELV),…

The stock market continues to be a challenging environment with rising rates a potent headwind. So far, the economy has been stable enough so that earnings growth has not contracted, but this is unlikely to persist the longer the Fed stays hawkish. This article discusses characteristics of stocks that are…

October is infamous for "jinxing" investors with massive drops — the last thing anyone wants following September's fall.

The stock market has given back the bulk of its gains following a stronger than expected inflation print. Amid these challenging circumstances, investors should consider high-quality, defensive stocks like Elevance Health (ELV) and Northrop Grumman (NOC).

Elevance Health Inc (NYSE: ELV) (previously known as Anthem) remains one of the leading health insurers in the U.S., providing medical benefits to roughly 45 million medical members.

Upgrades

Someone with a lot of money to spend has taken a bullish stance on Elevance Health (NYSE:ELV). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.